✦ LIBER ✦

PHP206 Assessing the Value of Access to Individual Patient Data for Reimbursement Decisions

✍ Scribed by A. Manca

Book ID: 119312705
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 67 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.08.748

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Data for Decision Making project: as

The Data for Decision Making project: assessment of surveillance systems in developing countries to improve access to public health information

✍ K. Wilkins; P. Nsubuga; J. Mendlein; D. Mercer; M. Pappaioanou 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 190 KB

390: The added value of second trimester

390: The added value of second trimester uterine artery Doppler in the identification of nulliparous women at increased risk for preeclampsia: an individual patient data metaanalysis

✍ Emily Kleinrouweler; Patrick Bossuyt; Joris van der Post; Javier Arenas; Koen De 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 438 KB

Re: Tamoxifen for the prevention of brea

Re: Tamoxifen for the prevention of breast cancer. Eur J Cancer 36 2000, 142–150. Relationship of trial design to value of data for patient?

✍ H. Thornton 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 54 KB

PCN129 USE OF ELECTRONIC MEDICAL RECORDS

PCN129 USE OF ELECTRONIC MEDICAL RECORDS (EMR) FOR ONCOLOGY OUTCOMES RESEARCH: ASSESSING THE COMPARABILITY OF EMR INFORMATION TO PATIENT REGISTRY AND HEALTH CLAIMS DATA

✍ E.L. Lau; F.S. Mowat; M.A. Kelsh; J. Legg; N.M. Engel-Nitz; H.N. Watson; H. Coll 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Donepezil for the symptomatic treatment

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials

✍ Anne Whitehead; Carlos Perdomo; Raymond D. Pratt; Jacqueline Birks; Gordon K. Wi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 3 views

## Abstract ## Background The objective was to evaluate the efficacy and tolerability of donepezil (5 and 10 mg/day) compared with placebo in alleviating manifestations of mild to moderate Alzheimer's disease (AD). ## Method A systematic review of individual patient data from Phase II and III do

Individual patient data meta-analysis of

Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches for estimating the hazard ratio under a random effects model

✍ Jack Bowden; Jayne F Tierney; Mark Simmonds; Andrew J Copas; Julian PT Higgins 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB